Question 1

Am I eligible for this trial based on my current health and COVID-19 status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for COVID-19?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

Question 5

What side effects should I be aware of while taking this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I receive any follow-up care after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 clinical trial (NCT04522830). Contact the study team or your healthcare provider for specific answers.

What this study is about